ACT-10041239 is under clinical development by Idorsia Pharmaceutical and currently in Phase I for Multiple Sclerosis.

If you have multiple sclerosis (MS) and are hoping to get pregnant, the news is good: MS itself does not make a pregnancy ...

ANK-700 is under clinical development by Anokion and currently in Phase I for Relapsing Remitting Multiple Sclerosis (RRMS).

Many people living with the degenerative neurological disease multiple sclerosis (MS) are premenopausal women. This means ...

An investigational drug for multiple sclerosis from Io Therapeutics has restored leg mobility and myelin nerve coatings in ...

Certain health issues seen in youth with MS in the five years before diagnosis confirm a prodromal period may exist in ...

Today, Kellien is still going through treatment for her form of M.S. bouncing between Iowa and Nebraska for more infusions every six months. She’ll live with M.S. for the rest of her live but wont let ...

Children and adolescents with multiple sclerosis (MS) have a range of symptoms, signs, and diagnoses within five years before ...

In new court filings, Karen Spencer accuses her ex-husband Charles Spencer of a “long-term” affair with Dr. Cat Jarman, his ...

The following is a summary of “Effects of COVID-19 Infection on Symptom Severity and Disability in Multiple Sclerosis,” ...

Columnist Ben Hofmeister is learning that navigating life with multiple sclerosis is a journey, rather than a quest or an adventure.

Analysis of Biogen's stock performance in 2024, focusing on sales struggles, financial health, and valuation. Read more here.